While the UK is not short of life science start-up companies there is a disconnect when it comes to scaling up, with many choosing to relocate to other markets with perceived better opportunities, writes Sarah Brereton, Director at Limewash Media.
Total Deal Value of Up to $770.5 million including Upfront Payment and Potential Milestone Payments
Autifony Eligible to Receive Royalties on Future Net Sales
.
Autifony Therapeutics Ltd: Autifony Announces Exclusive Global License and Collaboration Agreement with Jazz Pharmaceuticals on Two Ion Channel Targets for Neurological Disorders finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Autifony Therapeutics Limited: Autifony Therapeutics announces commencement of a US Phase Ib study of AUT00201, a novel Kv3 modulator, in Progressive Myoclonic Epilepsy-7 (EPM7) finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.